Bradley Mark Christopher
Transaction: 08/03/2026
SELL
Change
-2,572
Price
$26.37
Filing
08/05/2026
Type
SELL
Alumis Inc.
ALMS • Biotechnology
$6.34
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$809.56M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 4.34Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.34
Change0.00%
Shares Out127.69M
Market Cap$809.56M
Enterprise Value$343.69M
52W Range3.76 - 31.35
Beta-0.67
P/E-1.84
P/S109.43
P/B1.79
P/FCF-2.30
EV/Sales46.46
Price$6.34
Change0.00%
Shares Out127.69M
Market Cap$809.56M
Enterprise Value$343.69M
52W Range3.76 - 31.35
Beta-0.67
P/E-1.84
P/S109.43
P/B1.79
P/FCF-2.30
EV/Sales46.46
EV/EBITDA-0.75
EV/FCF-0.98
Earnings Yield-54.22%
FCF Yield-43.46%
Dividend Yield0.00%
Gross Margin85.46%
Oper. Margin-17.76%
Profit Margin-10.12%
Debt/Eq0.12
Current Ratio4.34
Quick Ratio4.34
Target$29.57
Target Upside366.40%
Target Median$29.00
Target Range15.00 - 40.00
Volume807.63K
Avg Volume1.28M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 4.34Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-10-20
94/100
Bullish
Bullish
7
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$25.00
Mean
$39.17
Median
$39.50
High
$51.00
Insider Transactions
Recent executive and insider activity
Drappa Jorn
Transaction: 08/03/2026
SELL
Change
-2,447
Price
$26.37
Filing
08/05/2026
Type
SELL
Goldstein David M
Transaction: 08/03/2026
SELL
Change
-2,596
Price
$26.37
Filing
08/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bradley Mark Christopher | SELL | -2,572 | $26.37 | 08/03/2026 | 08/05/2026 |
| Drappa Jorn | SELL | -2,447 | $26.37 | 08/03/2026 | 08/05/2026 |
| Goldstein David M | SELL | -2,596 | $26.37 | 08/03/2026 | 08/05/2026 |
| Hardiman Roy C. | SELL | -2,692 | $26.37 | 08/03/2026 | 08/05/2026 |
| Pangali Sanam | SELL | -1,364 | $26.37 | 08/03/2026 | 08/05/2026 |
| Schroer John R. | SELL | -3,282 | $26.37 | 08/03/2026 | 08/05/2026 |
| Pangali Sanam | SELL | -5,000 | $28.00 | 07/06/2026 | 07/08/2026 |
| Pangali Sanam | SELL | -5,000 | $5.06 | 07/06/2026 | 07/08/2026 |
| AKKARAJU SRINIVAS | BUY | +3,553 | Not reported | 06/30/2026 | 07/02/2026 |
| AKKARAJU SRINIVAS | BUY | +15,528 | $28.14 | 06/30/2026 | 07/02/2026 |
| Machado Patrick | BUY | +3,553 | Not reported | 06/30/2026 | 07/02/2026 |
| Machado Patrick | BUY | +15,528 | $28.14 | 06/30/2026 | 07/02/2026 |
| Srivastava Sapna | BUY | +3,553 | Not reported | 06/30/2026 | 07/02/2026 |
| Srivastava Sapna | BUY | +15,528 | $28.14 | 06/30/2026 | 07/02/2026 |
| Yao Zhengbin | BUY | +15,528 | $28.14 | 06/30/2026 | 07/02/2026 |
| Yao Zhengbin | BUY | +3,553 | Not reported | 06/30/2026 | 07/02/2026 |
| TETRAULT LYNN A. | BUY | +3,553 | Not reported | 06/30/2026 | 07/02/2026 |
| TETRAULT LYNN A. | BUY | +15,528 | $28.14 | 06/30/2026 | 07/02/2026 |
| Drappa Jorn | BUY | +11,317 | $8.84 | 05/22/2026 | 05/27/2026 |
| Drappa Jorn | SELL | -11,317 | $8.84 | 05/22/2026 | 05/27/2026 |